Denmark· DK-28105806916
Nerlynx
A neratinib product containing neratinibmaleat, registered in Denmark by Pierre Fabre Medicament. The same ATC class is registered in 13 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Neratinib is registered in 13 of 19 countries.
Countries holding a registration under ATC L01EH02 (neratinib), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Neratinib · ATC L01EH02
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Neratinibmaleat
- Manufacturer
- Pierre Fabre Medicament
- Country
- Denmark (DK)
- ATC code
- L01EH02
- ATC class
- Neratinib
- Defined daily dose
- 0.24 g, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28105806916
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
226 interactions on record for neratinib.
Graded by severity as the source publishes them — 97 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Neratinib · interactions on record
226 records
- 97 severe
- 123 moderate
- 6 minor
Most severe, free to view
- ClotrimazoleA01AB18severe
- CimetidineA02BA01severe
- RanitidineA02BA02severe
- FamotidineA02BA03severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under L01EH02
Neratinib, as other registers publish it.
- United StatesNerlynxPuma Biotechnology, Inc.
- PolandNerlynxPierre Fabre Medicament
- IcelandNerlynxPierre Fabre Medicament
- NorwayNerlynxPierre Fabre Medicament
- United StatesNerlynxPuma Biotechnology, Inc.
- FinlandNerlynxPierre Fabre Medicament
- CzechiaNERLYNXPIERRE FABRE MEDICAMENT, Lavaur
- CanadaNERLYNXKNIGHT THERAPEUTICS INC.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b3b59e61-5afc-4ac5-85a5-7a80d982fd3a GET /v1/drugs/b3b59e61-5afc-4ac5-85a5-7a80d982fd3a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "filmovertrukne tabletter",
"source": "dkma",
"strength": "40 mg",
"auth_role": "MOD",
"dk_drugid": "28105806916",
"substance": "Neratinibmaleat",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "43343"
}See everything about neratinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.